2016
DOI: 10.18203/2320-1770.ijrcog20160367
|View full text |Cite
|
Sign up to set email alerts
|

A randomized controlled trial of vaginal misoprostol tablet and intracervical dinoprostone gel in labor induction of women with prolonged pregnancies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2019
2019
2019
2019

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 15 publications
0
1
0
Order By: Relevance
“…4 With regard to prostaglandin administration, a prostaglandin E2 (dinoprostone, PGE2) vaginal suppository is the preferred method for cervical ripening and induction of labor, and it is widely used in clinical practice. 5 PGE2 is the only prostaglandin that is approved by the Food and Drug Administration of the United States for cervical ripening in pregnant women near or at term with a medical or obstetric indication. 6 The controlled-release vaginal PGE2 not only relaxes cervical smooth muscle and promotes cervical dilatation, but also stimulates the synthesis and release of endogenous PGE2.…”
Section: Introductionmentioning
confidence: 99%
“…4 With regard to prostaglandin administration, a prostaglandin E2 (dinoprostone, PGE2) vaginal suppository is the preferred method for cervical ripening and induction of labor, and it is widely used in clinical practice. 5 PGE2 is the only prostaglandin that is approved by the Food and Drug Administration of the United States for cervical ripening in pregnant women near or at term with a medical or obstetric indication. 6 The controlled-release vaginal PGE2 not only relaxes cervical smooth muscle and promotes cervical dilatation, but also stimulates the synthesis and release of endogenous PGE2.…”
Section: Introductionmentioning
confidence: 99%